As of June 4, 2025, Neoimmunetech Inc (950220.KQ) reports a Gross Margin of 7775.20%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Comparing Neoimmunetech Inc's Gross Margin to Peers
To better understand Neoimmunetech Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| Neoimmunetech Inc (950220.KQ) | 7775.20% |
| Regeneron Pharmaceuticals Inc (REGN) | 87.01% |
| Vertex Pharmaceuticals Inc (VRTX) | 86.11% |
| Gilead Sciences Inc (GILD) | 78.26% |
| Biogen Inc (BIIB) | 77.18% |
| Moderna Inc (MRNA) | 70.06% |
Compared to its competitors, Neoimmunetech Inc's Gross Margin is higher than all peers, indicating superior product pricing power or cost efficiency in production.